Hi Mate , please do not forget one thing : At the moment - since last unblinding in September 2009 by the IMB of Agenda - the actual testresults of Agenda are not known (at least they should not be known other than by the IMB) . Ray himself published it that the Agenda trial shall continue to be a double blinded test as it has been in the past.
This is the only sure thing ,that till now , no recent infos are available regarding OS.
The positive finding is - in my opinion - that on the long term Agenda (demonstrated in this particular clip )showed some slight advantage in comparision to Dacarbacine alone.IF , one more time IF !! , these OS numbers are better than from the former study 301 ... than we have a better perspective .
Cheers , BG
